炎症性肠病与新发IgA肾病的关联
基于日本全国性流行病学队列约431万成人回顾性分析,中位随访1089天,炎症性肠病者新发IgA肾病风险更高(HR 1.96,95%CI 1.29–2.99),提示两者存在潜在关联。
要点
- 炎症性肠病与IgA肾病新发风险约增加1倍相关(HR 1.96)。
- 炎症性肠病组IgA肾病发病比3.43(95%CI 2.26–5.21),无IBD组1.74(1.68–1.81)。
- IBD人群累积发病率更高,log-rank P=0.0028。
核心结论
- 在一般人群中,炎症性肠病与新发IgA肾病风险升高存在潜在关联。
研究设计与样本
- 回顾性分析日本JMDC索赔数据库4,311,393名成人,按有无炎症性肠病分组。
主要发现
- 中位随访1089天,炎症性肠病组IgA肾病发病比3.43(95%CI 2.26–5.21),无IBD组1.74(1.68–1.81)。
- Kaplan–Meier曲线显示IBD组累积发病率更高(log-rank P=0.0028)。
- 多变量Cox回归显示IBD者新发IgA肾病风险更高(HR 1.96,95%CI 1.29–2.99)。
临床怎么用
- 对炎症性肠病患者应关注IgA肾病相关临床表现,必要时进行筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: We analyzed a nationwide epidemiologic cohort including approximately 4,000,000 individuals. We found a potential association of inflammatory bowel disease with a greater risk of developing IgA nephropathy. BACKGROUND: There have been scarce epidemiologic data on the relationship between inflammatory bowel disease and the incidence of IgA nephropathy. In this study, we assessed whether inflammatory bowel disease was associated with a higher risk of developing IgA nephropathy using a large-scale epidemiologic cohort. METHODS: We retrospectively analyzed 4,311,393 adults enrolled in the JMDC Claims Database (previously known as the Japan Medical Data Center database), a nationwide epidemiologic database in Japan. The definitions of IgA nephropathy and inflammatory bowel disease (ulcerative colitis or Crohn disease) were based on International Classification of Diseases, 10th Revision codes. Individuals who had a history of IgA nephropathy were excluded. Study participants were categorized into two groups according to the presence of inflammatory bowel disease. Clinical outcomes were collected between January 2005 and May 2022. The primary outcome was incident IgA nephropathy. RESULTS: Median (interquartile range) age was 44 (36–53) years, and 2,497,313 (58%) were men. Inflammatory bowel disease was observed in 18,623 individuals (0.4%). Over a median follow-up of 1089 (532–1797) days, there were 2631 incidences of IgA nephropathy and 22 incidences in individuals without and with inflammatory bowel disease, yielding incident ratios with 95% confidence intervals of 1.74 (1.68–1.81) and 3.43 (2.26–5.21), respectively. Kaplan–Meier curves and the log-rank test showed that a cumulative incidence of IgA was higher in individuals with inflammatory bowel disease compared with those without (log-rank P = 0.0028). Multivariable Cox regression analysis demonstrated that individuals with inflammatory bowel disease were at higher risk of incident IgA nephropathy (hazard ratio, 1.96; 95% confidence interval, 1.29 to 2.99). CONCLUSIONS: We demonstrated the potential association of inflammatory bowel disease with higher risk of developing IgA nephropathy in a general population.
引用
- Nakayama T, Kaneko H, Okada A, et al. Association of Inflammatory Bowel Disease with Incident IgA Nephropathy. Clin J Am Soc Nephrol. 2024. PMID: 38600627. doi:10.2215/CJN.0000000000000457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。